Journal of Orthopaedics, vol.13, no.4, pp.316-321, 2016 (Scopus)
Aim We aimed to reveal whether there are prospective suggestions for effective and standard platelet-rich plasma applications. Methods We searched for clinical trials and traced all the references of incorporated documents. Results In literature, there was no study indicating which disease is treated by which mechanism of action, how much dose and content are prepared and applied, when the treatment is applied and how many cures are applied. Conclusion Guides introducing which concentrations of PRP are used for which diseases are to be prepared immediately by a committee which is comprised of primarily orthopedists, clinical pharmacologists and toxicologists.